Your browser doesn't support javascript.
loading
Developing an immune signature for triple-negative breast cancer to predict prognosis and immune checkpoint inhibitor response.
Wang, Ce; Feng, Guoshuang; Zhu, Jingjing; Wei, Kecheng; Huang, Chen; Wu, Zhenyu; Yu, Yongfu; Qin, Guoyou.
Afiliación
  • Wang C; Department of Biostatistics, School of Public Health, & The Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China.
  • Feng G; Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University & Capital Medical University, Beijing 100083, China.
  • Zhu J; Big Data & Engineering Research Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.
  • Wei K; Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University & Capital Medical University, Beijing 100083, China.
  • Huang C; Department of Biostatistics, School of Public Health, & The Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China.
  • Wu Z; Department of Biostatistics, School of Public Health, & The Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China.
  • Yu Y; Department of Biostatistics, School of Public Health, & The Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China.
  • Qin G; Department of Biostatistics, School of Public Health, & The Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China.
Future Oncol ; 18(9): 1055-1066, 2022 Mar.
Article en En | MEDLINE | ID: mdl-35105171
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pronóstico / Regulación Neoplásica de la Expresión Génica / Neoplasias de la Mama Triple Negativas / Inhibidores de Puntos de Control Inmunológico Tipo de estudio: Evaluation_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Future Oncol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pronóstico / Regulación Neoplásica de la Expresión Génica / Neoplasias de la Mama Triple Negativas / Inhibidores de Puntos de Control Inmunológico Tipo de estudio: Evaluation_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Future Oncol Año: 2022 Tipo del documento: Article País de afiliación: China